Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Ipsen: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Ipsen
Ipsen
Active
Website
LinkedIn
X
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Ipsen.
PL
Philippe Lopes-Fernandes
Executive Vice President, Chief Business Officer, Member of the Executive Committee
DB
Dominique Brard
Executive Vice President, Human Resources
SS
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
PM
Paul Murasko
Head of Digital Customer Interaction for North America
EV
Elisabeth Vey
Analytical Development Leader
HB
Henri Beaufour
Directors
CJ
Christophe Jean
Executive Vice President, Strategy and Business Development
AM
Aurélie Martin
Bioinformatics Engineer
TB
Tim Bourque
Associate Director of Warehousing & Logistics
Leadership Team
Key people at Ipsen.
PL
Philippe Lopes-Fernandes
Executive Vice President, Chief Business Officer, Member of the Executive Committee
Dominique Brard
Executive Vice President, Human Resources
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
PM
Paul Murasko
Head of Digital Customer Interaction for North America
Elisabeth Vey
Analytical Development Leader
HB
Henri Beaufour
Directors
CJ
Christophe Jean
Executive Vice President, Strategy and Business Development
Aurélie Martin
Bioinformatics Engineer
TB
Tim Bourque
Associate Director of Warehousing & Logistics
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Nov 18, 2021
BAKX Therapeutics
$25.0M Series A
Yibing Shan
Philippe Lopes-Fernandes
,
Sherpa Healthcare Partners
Feb 1, 2020
Xilio Therapeutics
$100.0M Series B
Jayson Punwani
Abingworth
,
Bain Capital Life Sciences
,
MRL Ventures Fund
,
RiverVest
,
SV Health Investors
, Giovanni Ferrara
,
Atlas Venture
,
Bay City Capital
, F-Prime Capital
, M Ventures
, Nancy Hong
,
Solasta Ventures
, Michael Ross
Jul 1, 2019
Pyxis Oncology
$22.0M Series A
Bayer
Agent Capital
,
Longwood Fund
Feb 16, 2017
Rhythm Pharmaceuticals
$41.0M Debt
—
Deerfield Management
,
MPM Capital
,
New Enterprise Associates
,
OrbiMed
,
Third Rock Ventures
Jun 13, 2012
Rhythm Pharmaceuticals
$25.0M Series B
—
Marc de Garidel
, Vaughn Kailian
, Ed Mathers
, Lou Tartaglia
Nov 1, 2010
Syntaxin
$29.0M Series C
—
Abingworth
,
Red Tree Venture Capital
, Johnson & Johnson Innovation
, LSP
,
Lundbeckfond Ventures
,
Quest Ventures
,
Seventure Partners
,
SR One
Mar 1, 2010
Rhythm Pharmaceuticals
$40.0M Series A
New Enterprise Associates
, Todd Foley
Foresite Capital
,
T1D Fund
,
Venrock
,
Deerfield Management
, Jonathan Silverstein
,
Third Rock Ventures
,
Wellington Management
